Tradestie Institutional Equity Comparison Engine

HQL vs THW โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HQL Overall Edge

HQL Captures Institutional Edge (1โ€“0 Pillars ยท 1โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to abrdn Life Sciences Investors (HQL) driven by superior Momentum & Technical. Fundamentally, HQL trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus THW at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, HQL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against THW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
HQL N/M vs THW N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner HQL
1Y +5.9% vs +2.3% ยท 52W Pos 30% vs 52%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
HQL NYSE
abrdn Life Sciences Investors
Institutional Equity
$17.76
-2.84% 1D
Market Cap $455.0M
1M Return +5.84%
1Y Return +5.9%
Forward P/E N/M
Unified AI Score
46.0 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 60.0
THW NYSE
abrdn World Healthcare Fund
Institutional Equity
$12.91
-1.71% 1D
Market Cap $510.6M
1M Return +6.82%
1Y Return +2.3%
Forward P/E N/M
Unified AI Score
36.7 / 100 SELL
Tech 34.0 Fund 42.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: HQL +5.9% THW +2.3% Spread: +3.6 pp (HQL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
HQL TTM Op. Margin: N/A THW TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HQL vs THW. Trailing 12-month operating profitability (HQL N/A vs THW N/A) and valuation multiples (HQL N/M vs THW N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: HQL (1) vs THW (3)
Institutional Metric HQL THW Criterion Row Winner
Market Capitalization Scale $455.0M $510.6M Larger Scale THW
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 30% ($16โ€“$23) 52% ($11โ€“$14) Stronger Trend THW
Beta / 30D Volatility Risk Regime 0.90ฮฒ ยท 39% Vol 0.71ฮฒ ยท 27% Vol Lower Realized Risk THW
Unified Institutional Score Composite Signal 46.0 / 100 (HOLD) 36.7 / 100 (SELL) Higher Composite HQL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full HQL vs THW Buy Guide
HQL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HQL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
THW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live THW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither HQL nor THW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.